Methylsulfonylnitrobenzoates, a New Class of Irreversible Inhibitors of the Interaction of the Thyroid Hormone Receptor and Its Obligate Coactivators That Functionally Antagonizes Thyroid Hormone
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Methylsulfonylnitrobenzoates, a New Class of Irreversible Inhibitors of the Interaction of the Thyroid Hormone Receptor and Its Obligate Coactivators That Functionally Antagonizes Thyroid Hormone
Authors
Keywords
-
Journal
JOURNAL OF BIOLOGICAL CHEMISTRY
Volume 286, Issue 14, Pages 11895-11908
Publisher
American Society for Biochemistry & Molecular Biology (ASBMB)
Online
2011-02-15
DOI
10.1074/jbc.m110.200436
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Molecular Aspects of Thyroid Hormone Actions
- (2010) Sheue-Yann Cheng et al. ENDOCRINE REVIEWS
- Identification and Characterization of 4-Chloro-N-(2-{[5-trifluoromethyl)-2-pyridyl]sulfonyl}ethyl)benzamide (GSK3787), a Selective and Irreversible Peroxisome Proliferator-Activated Receptor δ (PPARδ) Antagonist
- (2010) Barry G. Shearer et al. JOURNAL OF MEDICINAL CHEMISTRY
- Novel Flufenamic Acid Analogues as Inhibitors of Androgen Receptor Mediated Transcription
- (2009) Clémentine Féau et al. ACS Chemical Biology
- In VivoInteraction of Steroid Receptor Coactivator (SRC)-1 and the Activation Function-2 Domain of the Thyroid Hormone Receptor (TR) β in TRβ E457A Knock-In and SRC-1 Knockout mice
- (2009) Manuela Alonso et al. ENDOCRINOLOGY
- Regulation of Pyruvate Dehydrogenase Kinase 4 (PDK4) by Thyroid Hormone
- (2009) Ramy R. Attia et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Improvement of Pharmacological Properties of Irreversible Thyroid Receptor Coactivator Binding Inhibitors
- (2009) Jong Yeon Hwang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Thyroid hormones and the control of cell proliferation or cell differentiation: Paradox or duality?
- (2009) Elsa Kress et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Nuclear receptor drug discovery
- (2008) Taosheng Chen CURRENT OPINION IN CHEMICAL BIOLOGY
- Implications of the binding of tamoxifen to the coactivator recognition site of the estrogen receptor
- (2008) D. J Kojetin et al. ENDOCRINE-RELATED CANCER
- Structural and Biochemical Basis for the Binding Selectivity of Peroxisome Proliferator-activated Receptor γ to PGC-1α
- (2008) Yong Li et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Blocking Estrogen Signaling After the Hormone: Pyrimidine-Core Inhibitors of Estrogen Receptor-Coactivator Binding
- (2008) Alexander A. Parent et al. JOURNAL OF MEDICINAL CHEMISTRY
- Comprehensive Mechanistic Analysis of Hits from High-Throughput and Docking Screens against β-Lactamase
- (2008) Kerim Babaoglu et al. JOURNAL OF MEDICINAL CHEMISTRY
- Ligand induced interaction of thyroid hormone receptor beta with its coregulators
- (2008) Napoleão F. Valadares et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Complex actions of thyroid hormone receptor antagonist NH-3 on gene promoters in different cell lines
- (2008) Vanya Shah et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Access and Binding of Local Anesthetics in the Closed Sodium Channel
- (2008) I. Bruhova et al. MOLECULAR PHARMACOLOGY
- Tamoxifen (ICI46,474) as a targeted therapy to treat and prevent breast cancer
- (2006) V Craig Jordan BRITISH JOURNAL OF PHARMACOLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started